Plasma YKL-40 in the spectrum of neurodegenerative dementia

BACKGROUND: Increased plasma YKL-40 has been reported in Alzheimer’s disease (AD), but its levels in other neurodegenerative diseases are unknown. Here, we aimed to investigate plasma YKL-40 in the spectrum of neurodegenerative dementias. METHODS: YKL-40 was quantified in the plasma of 315 cases, in...

Descripción completa

Detalles Bibliográficos
Autores principales: Villar-Piqué, Anna, Schmitz, Matthias, Hermann, Peter, Goebel, Stefan, Bunck, Timothy, Varges, Daniela, Ferrer, Isidre, Riggert, Joachim, Llorens, Franc, Zerr, Inga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6624942/
https://www.ncbi.nlm.nih.gov/pubmed/31299989
http://dx.doi.org/10.1186/s12974-019-1531-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6624942/
https://www.ncbi.nlm.nih.gov/pubmed/31299989
http://dx.doi.org/10.1186/s12974-019-1531-3

Ejemplares similares